Air Canada and flight attendants union reach tentative deal, ending strike
Proactiveinvestors NA· 2025-08-19 15:45
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
TRYVIO™ (aprocitentan) now included in ACC/AHA Clinical Practice Guidelines for the treatment of hypertension
Globenewswire· 2025-08-19 15:45
The updated recommendations now include TRYVIO™ (aprocitentan) – the first and only hypertension treatment targeting the endothelin pathway.Endothelin is upregulated in hypertension and is a fundamental mediator in patients whose hypertension is difficult-to-control.Hypertension remains a major global health issue, and the number one modifiable risk factor of early morbidity/mortality. Allschwil, Switzerland & Radnor, Pennsylvania – August 19, 2025Idorsia Ltd (SIX: IDIA) announces that its novel dual endoth ...
Societe Generale: shares & voting rights as of 31 July 2025
Globenewswire· 2025-08-19 15:45
NUMBER OF SHARES COMPOSING CURRENT SHARE CAPITAL AND TOTAL NUMBER OF VOTING RIGHTS AS OF 31 JULY 2025 Regulated Information Paris, 19 August 2025 Information about the total number of voting rights and shares pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulations. DateNumber of shares composing current share capitalTotal number ofvoting rights31 July 2025785,180,327 Gross: 874,556,412 Press contacts: Jean-Baptiste Froville_+33 1 58 98 68 00_ jean-bapti ...
Apple Won't Have to Provide an Encryption Backdoor in the UK, Says US Official
CNET· 2025-08-19 15:38
Group 1 - The US Director of National Intelligence announced that Apple will not be required to provide an encryption backdoor in the UK, alleviating concerns about privacy and security [1][2] - The UK had initially demanded that Apple provide access to iCloud data for both British citizens and citizens of other countries for criminal investigations [3] - Apple previously removed the Advanced Data Protection feature in the UK due to the government's demands, expressing disappointment with the UK's Home Office [4] Group 2 - Recent reports indicated that the UK was reconsidering its original demands and seeking a resolution [5] - The agreement reached is expected to protect Americans' private data and uphold constitutional rights and civil liberties [2]
Will New Beverage Innovation Revive Starbucks' U.S. Comparable Sales?
ZACKS· 2025-08-19 15:36
Key Takeaways Starbucks' U.S. comparable sales fell 2% in Q3 2025, pressuring its core market performance.The Back to Starbucks plan centers on beverage innovation tied to health and premium trends.New drinks like protein cold foam and coconut water-based teas aim to boost transaction growth.Starbucks Corporation (SBUX) continues to face pressure in its core U.S. market, where comparable sales slipped 2% in the third quarter of fiscal 2025. Management is clear that turning around domestic performance will r ...
Housing Data Mixed for Starts, Permits and Home Depot Earnings
ZACKS· 2025-08-19 15:31
Tuesday, August 19, 2025Homebuilding news takes center stage this morning — in fact, this week has important housing data all through it — with Housing Starts and Building Permits for July pointing in two distinctly different directions. Pre-market futures were already showing some improvement from overnight lows, but have pointed north on the new data.Housing Starts, Building Permits Point to Big DifferencesLast month, Housing Starts came in at multi-month highs to 1.43 million seasonally adjusted, annuali ...
Target Q2 Earnings Preview: Key Trends Investors Should Watch
ZACKS· 2025-08-19 15:31
Key Takeaways Target Q2 sales are projected at $24.91B, down 2.1% year over year.Earnings are expected at $2.09 per share, a decline of 18.7% from last year.Digital growth and supply-chain gains may offset weak traffic and margin headwinds.The countdown is on for Target Corporation’s (TGT) second-quarter fiscal 2025 earnings release, set for Aug. 20, before the market opens.The Zacks Consensus Estimate for second-quarter revenues stands at $24.91 billion, indicating a decline of 2.1% from the same period la ...
Nvidia reportedly developing new AI chip for Chinese market
Proactiveinvestors NA· 2025-08-19 15:22
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
Lincoln Educational Services to Highlight Business Momentum at Several Upcoming Investor Events
Globenewswire· 2025-08-19 15:20
Demand for Skilled Labor Continues to Generate Growth Across the Company’s 22 CampusesParsippany, NJ, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC), a national leader in specialized technical training for more than 75 years, today announced that Scott Shaw, President and CEO, and Brian Meyers, Chief Financial Officer, will be attending several investor conferences in the coming weeks, highlighting the continued business momentum and growth drivers generating incre ...
24/7 Market News: LIXTE Biotechnology Spotlight- Revisiting the “Too Much of a Good Thing” Strategy for LB-100
Globenewswire· 2025-08-19 15:18
Core Insights - LIXTE Biotechnology's LB-100 is highlighted as a revolutionary cancer therapy that induces "lethal activation" in cancer cells, particularly colon cancer, leading to cell death [1][3] - The editorial in Nature Reviews Cancer emphasizes LB-100's unique mechanism of hyperactivating oncogenic signaling, which contrasts with traditional therapies that inhibit these pathways [4][7] - LIXTE is advancing its clinical trials for LB-100, which has shown a favorable toxicity profile and preliminary antitumor activity in phase I trials [6][10] Mechanism of Action - LB-100, a first-in-class PP2A inhibitor, hyperactivates oncogenic pathways, creating mitogenic stress that is lethal to tumor cells, especially when combined with stress-response inhibitors [5][11] - The approach targets the ideal level of oncogenic signaling, pushing it beyond survivable thresholds, which may represent a vulnerability in tumors [4][12] - Recent data indicate that LB-100's combination with WEE1 inhibitors can trigger tumor regression in colorectal and pancreatic cancer models [11][12] Clinical Development - LIXTE is currently conducting proof-of-concept trials for LB-100 in various cancer types, including Ovarian Clear Cell Carcinoma, Metastatic Colon Cancer, and Advanced Soft Tissue Sarcoma [10] - The company has reported prolonged disease stabilization and partial response in patients during early-stage clinical trials [6][10] - The editorial supports LIXTE's research strategy, validating the unique and radical approach of LB-100 in cancer treatment [12]